IBRUTINIB 140 mg (Ibrunat) x 30 Capsules

~~$400.00~~ $195.00

Prescription Required

Ibrutinib 140 mg (Ibrunat) is a targeted anticancer medicine used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinaemia (WM), and other approved conditions. It works by blocking a protein called Bruton’s tyrosine kinase (BTK), which helps cancer cells grow and survive. This slows the growth and spread of cancer cells.

Generic name	Ibrutinib
Strength	140 mg
Manufacturer	Natco
Package size	30 Capsules
Used for	Chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinaemia (WM)
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries.

Enquire via WhatsApp

Uses of IBRUTINIB 140 mg

Treats chronic lymphocytic leukaemia (CLL)
Treats mantle cell lymphoma (MCL)
Treats Waldenström macroglobulinaemia (WM)
Treats small lymphocytic lymphoma (SLL)
Used in other approved B-cell malignancies

Benefits

Targets cancer cells specifically
Slows disease progression
Helps improve treatment outcomes
Convenient oral therapy
Supports long-term disease management

How Does IBRUTINIB Work?

Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor. It blocks the BTK protein, which plays a key role in the growth and survival of abnormal B cells. By inhibiting BTK, Ibrutinib helps stop cancer cells from multiplying and promotes their destruction.

Side Effects

Diarrhoea
Fatigue
Nausea
Bruising or bleeding
Muscle or joint pain
Rash
Low blood cell counts
Increased risk of infections

Precautions

Take the medicine exactly as prescribed by your doctor.
Inform your doctor if you have a history of bleeding disorders, heart disease, or liver problems.
Attend regular blood tests to monitor blood cell counts and liver function.
Avoid grapefruit and Seville oranges during treatment.
Tell your healthcare provider about all medicines and supplements you are taking.
Report unusual bleeding, fever, or signs of infection immediately.
Do not stop treatment without consulting your oncologist.

Author

Reviewed By

Dr. Neeru Mehta

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.